New York-Presbyterian Fund Inc
THE PURPOSES FOR WHICH THE CORPORATION IS FORMED ARE: (A) TO RECEIVE, SOLICIT, AND ADMINISTER A FUND OR FUNDS TO BE APPLIED EXCLUSIVELY FOR CHARITABLE, EDUCATIONAL, AND SCIENTIFIC PURPOSES OF THE NEW YORK AND PRESBYTERIAN HOSPITAL AND ANY OTHER HEALTH-CARE RELATED CHARITABLE ORGANIZATION OR CORPORATION APPROVED BY THE BOARD OF DIRECTORS OF THE CORPORATION WHICH IS DESCRIBED IN SECTION 509(A)(1) OR 509(A)(2) OF THE INTERNAL REVENUE CODE OF 1954, AS AMENDED AND (B) TO TAKE ANY AND ALL ACTIONS WHICH ARE Incidental TO AND NOT INCONSISTENT WITH THE FORGOING PURPOSES OF THE CORPORATION AND WHICH ARE LAWFUL FOR NOT-FOR-PROFIT CORPORATIONS, TO THE EXTENT SUCH PURPOSES ARE PURPOSES DESCRIBED IN SECTION 509(A)(3)(A) OF THE INTERNAL REVENUE CODE OF 1954.
Founded
2001
Web
Sign in to see organisation website
Address
New York City
From Social media
News about from their social media (Facebook and X).
Data about organisation
Interesting nearby
Interesting organisations close by to residence of New York-Presbyterian Fund Inc
MOUNT SINAI MEDICAL CENTER INC
The Mount Sinai Hospital is one of the nation’s oldest, largest, & most respected hospitals.
Children of Peru Foundation, Inc.
Tax exempt (501c3) US charity based in NY & working to provide a better education & healthcare to un.
Join us and make a difference for the future!
Sign Up
Please fill in your information. Everything is free, we might contact you with updates (but cancel any time!)
Sign in with GoogleOr
Good News
Great news for the multiple myeloma community! 🎉 Blenrep has been approved by the US FDA, offering new hope for patients in need of effective treatments. With a significant reduction in death risk, this is a step forward in improving lives! 💪 #HealthcareInnovation #MultipleMyeloma #GoodNews
Blenrep approved by US FDA for use in treatment of relapsed/refractory multiple myeloma - GSK (NYSE:GSK)
Benzinga
Like Comment